A patient with rheumatoid arthritis has recently received diagnostic results indicating elevated inflammatory markers, mild anemia, and early signs of osteoporosis. Which nursing intervention is most appropriate to address the patient's risk of osteoporosis?

A) Encourage the patient to perform weight-bearing exercises regularly.

B) Recommend increasing dietary intake of red meat to improve anemia.

C) Suggest reducing fluid intake to prevent joint swelling.

D) Advise taking over-the-counter antacids for bone health.

A patient with rheumatoid arthritis presents with elevated inflammatory markers and erosive joint changes despite ongoing treatment. Which nursing intervention is most appropriate to address the patient's risk of osteoporosis?

A) Encourage weight-bearing exercises and calcium-rich foods.

B) Increase the frequency of corticosteroid medication.

C) Suggest reducing protein intake to minimize stress on bones.

D) Advise complete rest to prevent further joint damage.

A patient with a history of rheumatoid arthritis presents with increased fatigue, shortness of breath on exertion, and new findings of interstitial lung changes. Laboratory results indicate worsening anemia with hemoglobin at 10.5 g/dL. What is the most appropriate initial nursing intervention to address her current respiratory symptoms?

A) Administer supplemental oxygen as prescribed

B) Educate the patient on energy conservation techniques

C) Encourage high-iron foods to improve anemia

D) Monitor vital signs closely for further deterioration

A patient with rheumatoid arthritis presents with increased fatigue, shortness of breath on exertion, borderline tachycardia, and elevated blood pressure. Auscultation reveals faint bibasilar crackles, and laboratory results show worsening anemia with hemoglobin at 10.5 g/dL. Which nursing intervention is most appropriate to prioritize in this clinical scenario?

D) Coordinate with the healthcare team to adjust DMARD therapy to control systemic inflammation.

A) Administer supplemental oxygen to improve oxygenation.

B) Encourage the patient to increase physical activity to improve cardiovascular health.

C) Prepare the patient for an iron infusion to address anemia.

D) Coordinate with the healthcare team to adjust DMARD therapy to control systemic inflammation.

A patient with rheumatoid arthritis has been transitioned from methotrexate to leflunomide due to interstitial lung changes. The patient is also experiencing anemia of chronic disease. Which nursing intervention is most appropriate to address both the pulmonary and hematologic complications in this patient?

B) Educate the patient on the importance of medication adherence to DMARDs and corticosteroids.

A) Administer supplemental oxygen to improve oxygenation and energy levels.

B) Educate the patient on the importance of medication adherence to DMARDs and corticosteroids.

C) Initiate a high-protein diet to enhance erythropoiesis and improve anemia.

D) Schedule pulmonary function tests to monitor lung status regularly.

A patient with rheumatoid arthritis and interstitial lung changes is undergoing treatment adjustments. Which intervention by the nurse is most appropriate to prioritize in monitoring the patient's response to the new treatment regimen?

A) Conducting weekly spirometry testing to assess lung function.

B) Evaluating the patient's skin for signs of rash or hypersensitivity reaction.

C) Monitoring serum ferritin levels monthly to assess anemia status.

D) Checking blood pressure daily to monitor corticosteroid side effects.

A patient with rheumatoid arthritis presents with increased dyspnea and a persistent dry cough, alongside new findings of pulmonary fibrosis on HRCT. Which nursing intervention is most appropriate to prioritize in managing this patient's current symptoms and condition?

B) Educate the patient on the importance of adhering to the increased corticosteroid and new immunosuppressant regimen.

A) Encourage the patient to perform deep breathing exercises and use incentive spirometry regularly.

B) Educate the patient on the importance of adhering to the increased corticosteroid and new immunosuppressant regimen.

C) Monitor the patient's oxygen saturation levels frequently and prepare for possible oxygen therapy initiation.

D) Coordinate with the dietary team to ensure the patient receives a low-sodium diet to minimize fluid retention.

A patient with rheumatoid arthritis and newly diagnosed pulmonary fibrosis is experiencing increased dyspnea and more pronounced bibasilar crackles. The healthcare team has decided to increase the dose of corticosteroids and initiate azathioprine. What is the priority nursing intervention to ensure the patient's safety during this change in treatment?

A) Monitor the patient's blood glucose levels regularly.

B) Educate the patient on the potential side effects of azathioprine.

C) Assess the patient's skin for signs of bruising or bleeding.

D) Schedule regular spirometry tests to assess lung function.

A patient with rheumatoid arthritis has been on increased corticosteroid therapy and recently started azathioprine. She now presents with fatigue, fever, weight loss, elevated liver enzymes, and elevated white blood cell count. What is the most appropriate nursing intervention to prioritize in this situation?

B) Notify the healthcare provider about the elevated liver enzymes and potential hepatotoxicity.

A) Encourage increased fluid intake to manage fever.

B) Notify the healthcare provider about the elevated liver enzymes and potential hepatotoxicity.

C) Educate the patient on dietary changes to address unintended weight loss.

D) Monitor the patient's oxygen saturation and respiratory status closely.

A patient with rheumatoid arthritis on azathioprine presents with fatigue, fever, unintended weight loss, and elevated liver enzymes. Which action should the nurse prioritize to address the potential hepatotoxicity and ensure safe medication management?

D) Collaborate with the healthcare provider to discuss the discontinuation or adjustment of azathioprine therapy.

A) Administer a dose of acetaminophen to address the fever.

B) Educate the patient about the signs and symptoms of liver dysfunction.

C) Prepare the patient for an immediate liver biopsy to assess liver damage.

D) Collaborate with the healthcare provider to discuss the discontinuation or adjustment of azathioprine therapy.

rheumatoid arthritis - Nursing Case Study

Pathophysiology

• Primary mechanism: Immune System Dysfunction - Rheumatoid arthritis (RA) begins with an autoimmune response where the immune system mistakenly attacks the synovial membrane, leading to chronic inflammation. This inflammation causes synovitis, characterized by swelling and pain in the affected joints.

• Secondary mechanism: Synovial Hyperplasia and Pannus Formation - Persistent inflammation results in synovial cell proliferation, creating a thickened synovial membrane known as pannus. The pannus invades and erodes cartilage and bone, leading to joint deformity and loss of function.

• Key complication: Joint Destruction and Systemic Effects - Over time, the destructive process can cause irreversible joint damage, decreased mobility, and increased disability. Systemic inflammation may also lead to complications such as cardiovascular disease, highlighting the importance of early diagnosis and management.

Patient Profile

Demographics:

57-year-old female, office manager

History:

• Key past medical history: Diagnosed with rheumatoid arthritis 5 years ago, hypertension, mild depression

• Current medications: Methotrexate, low-dose prednisone, lisinopril, sertraline

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing joint pain and stiffness

• Key symptoms: Swelling in hands and feet, morning stiffness lasting over an hour, fatigue, occasional low-grade fever

• Vital signs: Blood pressure 145/88 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F

Section 1

New Diagnostic Results:

As part of her ongoing management for rheumatoid arthritis, the patient underwent a series of diagnostic tests to evaluate the progression of her condition and assess for potential complications. The latest laboratory results revealed elevated inflammatory markers, with a C-reactive protein (CRP) level of 15 mg/L (normal: <5 mg/L) and an erythrocyte sedimentation rate (ESR) of 45 mm/hr (normal: 0-20 mm/hr). These findings suggest active inflammation, correlating with her reported increase in joint pain and stiffness. Additionally, a complete blood count (CBC) showed mild anemia with a hemoglobin level of 11.2 g/dL (normal: 12-16 g/dL), indicating the systemic effects of chronic inflammation.

Further imaging studies, including X-rays of the hands and feet, revealed erosive changes in the metacarpophalangeal and proximal interphalangeal joints, consistent with progressive joint destruction. These changes highlight the aggressive nature of her rheumatoid arthritis despite current treatment. The imaging also identified early signs of osteoporosis, a common complication in patients with RA, particularly those on long-term corticosteroid therapy. This necessitates consideration of additional interventions to address bone health.

The new diagnostic findings underscore the need for a comprehensive review of her current management plan. The healthcare team must weigh the benefits of intensifying disease-modifying antirheumatic drug (DMARD) therapy, possibly considering biologic agents, against the potential risks. Addressing the anemia may involve exploring underlying causes such as iron deficiency or chronic disease, which could require specific treatments. Finally, the implications of osteoporosis call for a discussion on preventive strategies, including calcium and vitamin D supplementation and potential pharmacotherapy, to reduce the risk of fractures.

Section 2

Change in Patient Status:

Two weeks after the latest diagnostic evaluation, the patient returned to the clinic with new complaints of increased fatigue and shortness of breath on exertion, which she noted was not present during her last visit. These symptoms prompted a thorough clinical assessment. On examination, her vital signs were notable for a borderline tachycardia, with a pulse rate of 102 beats per minute, and a slightly elevated blood pressure of 142/88 mmHg. Auscultation of the chest revealed faint bibasilar crackles, raising suspicion for potential pulmonary involvement, a known extra-articular complication of rheumatoid arthritis.

Given her new symptoms and the history of progressive disease, the healthcare team conducted further laboratory and imaging investigations. Repeat CBC confirmed a worsening anemia, with hemoglobin dropping to 10.5 g/dL. Additional tests, including a serum ferritin level, were performed to differentiate between iron deficiency anemia and anemia of chronic disease. A high-resolution CT scan of the chest was ordered, revealing interstitial lung changes suggestive of early rheumatoid lung disease, a complication that can arise in patients with long-standing RA.

These developments necessitate a reassessment of her treatment strategy, focusing on managing both her systemic inflammation and the newly identified pulmonary complications. The healthcare team must consider optimizing her DMARD therapy to control systemic disease activity while evaluating the need for pulmonary-specific interventions. Additionally, her anemia requires further exploration, and treatment may involve iron supplementation or other targeted therapies based on the underlying cause. This evolving clinical picture highlights the complexity of managing rheumatoid arthritis and underscores the importance of a multidisciplinary approach.

Section 3

Following the identification of interstitial lung changes and worsening anemia, the healthcare team initiated adjustments to the patient's treatment regimen. Methotrexate, a cornerstone in her DMARD therapy, was reassessed due to its potential pulmonary toxicity. The team decided to transition her to a different DMARD, such as leflunomide or sulfasalazine, with the aim of maintaining control over her systemic inflammation while minimizing risks to her pulmonary health. A pulmonologist was consulted to provide expert input on the management of her early-stage rheumatoid lung disease. The recommendation included starting a low-dose corticosteroid to address the lung inflammation, with a plan to monitor her respiratory status closely.

In parallel, the patient's anemia was further evaluated. Her serum ferritin level was found to be elevated, consistent with anemia of chronic disease rather than iron deficiency anemia. As a result, the team decided against iron supplementation and focused on addressing the underlying inflammation to improve her anemia. Erythropoiesis-stimulating agents were considered, but given the patient's overall condition, the decision was made to first observe the response to the adjusted DMARD therapy and the corticosteroid intervention.

Over the next few weeks, the patient experienced some improvement in her fatigue and exertional shortness of breath, suggesting a positive response to the treatment modifications. However, the persistence of faint bibasilar crackles on auscultation indicated that her pulmonary condition required ongoing surveillance. The healthcare team emphasized the importance of regular follow-up visits to monitor her lung function, blood counts, and overall disease activity, recognizing the need for a dynamic approach to her evolving clinical picture. This stage of management illustrates the importance of integrating multidisciplinary care and patient-centered strategies to address the multifaceted challenges of rheumatoid arthritis with extra-articular complications.

Section 4

Several weeks into the revised treatment plan, the patient's clinical status took a concerning turn. During a routine follow-up visit, she reported increased dyspnea and a persistent dry cough, which had worsened since the last appointment. On examination, her vital signs indicated mild tachypnea with a respiratory rate of 22 breaths per minute, but her oxygen saturation remained stable at 94% on room air. Auscultation revealed more pronounced bibasilar crackles compared to previous visits, suggesting a progression in her pulmonary condition. These findings prompted the healthcare team to expedite further diagnostic evaluations.

A high-resolution computed tomography (HRCT) scan of the chest was conducted to gain a clearer picture of the changes in her pulmonary status. The results revealed increased interstitial markings and a pattern consistent with pulmonary fibrosis, a known complication associated with rheumatoid arthritis. Although her inflammatory markers, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), showed a slight decrease, indicating some control over systemic inflammation, the progression of lung involvement necessitated a reevaluation of her treatment plan.

Given these developments, the healthcare team decided to increase the dose of her corticosteroid therapy temporarily to address the exacerbation of her pulmonary symptoms. Additionally, the pulmonologist recommended initiating a trial of a more aggressive immunosuppressant, such as azathioprine, to better manage the interstitial lung disease. The team acknowledged the need to balance the benefits of intensified treatment against potential side effects, emphasizing the importance of close monitoring. This phase of her management highlighted the complexities of treating rheumatoid arthritis with extra-articular involvement and underscored the necessity of a flexible, patient-centered approach as the patient's condition evolved.

Section 5

Several weeks after the escalation of her treatment plan, the patient presented for a follow-up evaluation. Initially, she reported a slight improvement in her breathing, attributing it to the increased corticosteroid dose. However, she expressed new concerns about experiencing persistent fatigue, occasional fever, and unintended weight loss despite her stable dietary habits. On examination, her vital signs showed a low-grade fever of 37.8°C (100°F) and a heart rate of 98 beats per minute. While her respiratory rate had decreased to 20 breaths per minute, her oxygen saturation remained at 93% on room air, slightly lower than previous readings.

In light of these new symptoms and findings, the healthcare team ordered a comprehensive set of laboratory tests, including a complete blood count, liver function tests, and a repeat of her inflammatory markers. The results were revealing; her white blood cell count was elevated at 12,000/mm³, indicating a possible infectious or inflammatory process. Liver enzymes were mildly elevated, raising concerns about potential hepatotoxicity, likely related to the recent introduction of azathioprine. Meanwhile, her CRP and ESR had plateaued, suggesting persistent systemic inflammation despite treatment adjustments.

These results prompted the team to reconsider her current medication regimen. The potential hepatotoxicity of azathioprine necessitated a careful reevaluation of its continued use versus the need for alternative immunosuppressants. Additionally, the possibility of an occult infection required further investigation, leading to the decision to perform blood cultures and consider empirical antibiotic therapy. This phase of her care emphasized the intricate balance of managing the multifaceted complications of rheumatoid arthritis while attending to emerging side effects of treatment, necessitating ongoing vigilance and adaptation of her management plan.